drug

rilpivirine

1 story · latest Oct 30, 2026

Follow rilpivirine. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved May 2011 · NDA202022, NDA219016
Brands: Edurant, Edurant Ped
Trials: 3 registered trials in coverage

Relationships

Developed by Johnson & Johnson

Also known as

rilpivirine hydrochloride

Timeline

GSK's Benlysta label updated by FDA; Phase 2a NASH trial posts results

Oct 30Weekly roundup, 10 itemsaletekitug AmgenUpdated

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.